G protein receptor kinase type 2: A novel target in cardiovascular drug development
In spite of significant advancement in pharmacotherapy, heart failure remains one of the main causes of death worldwide. The existing treatment of heart failure prolongs life span by slowing down the pathological process but does not induce heart healing. The β adrenergic receptor dysfunction is a h...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Srpsko lekarsko drustvo
2014-01-01
|
| Series: | Hospital Pharmacology |
| Subjects: | |
| Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2014/2334-94921402109V.pdf |